Regeneron’s REGN-EB3 Proves Superior as Treatment for Ebola in Clinical Trial
source: pixabay.com

Regeneron’s REGN-EB3 Proves Superior as Treatment for Ebola in Clinical Trial

According to a story from PR Newswire, the biotechnology company Regeneron Pharmaceuticals, Inc., recently announced the release of data from a clinical trial comparing four experimental treatments for Ebola virus…

Continue Reading Regeneron’s REGN-EB3 Proves Superior as Treatment for Ebola in Clinical Trial
Close Menu